AIVITA Biomedical
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18301 Von Karman Ave Ste 130, Irvine, Ca...Phone Number
(949) 872-2555Website
www.aivitabiomedical.comRevenue
$11 MillionIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
3
3
3
4
3
About AIVITA Biomedical
AIVITA Biomedical is a biotechnology company focused on developing personalized vaccines for the prevention of infectious diseases and the treatment of cancer. They utilize a unique pan-antigenic approach to target all neoantigens, allowing their cancer treatments to adapt to mutations over time. Their autologous cell therapy platform has produced multiple therapeutic vaccine programs that have shown safety and efficacy in early clinical trials. AIVITA's expertise in stem cell growth and differentiation enables them to create efficient and economical manufacturing processes for therapeutic development.Explore more
AIVITA Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AIVITA Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once AIVITA Biomedical has new funding data
Click to see if AIVITA Biomedical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if AIVITA Biomedical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AIVITA Biomedical launches new products
Earning: See what the market has to say on AIVITA Biomedical recently announced quarterly report
AIVITA Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at AIVITA Biomedical
Check if AIVITA Biomedical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at AIVITA Biomedical
Find 3 more new buyers
Compare Similar Companies to AIVITA Biomedical
Compare insights from companies similar to AIVITA Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AIVITA Biomedical is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
AIVITA Biomedical is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about AIVITA Biomedical.
AIVITA Biomedical financials insights
Gather financial insights about AIVITA Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$2M
2020
Series B
$62.5M
AIVITA Biomedical Tech Stack
A closer look at the technologies used by AIVITA Biomedical
See more technologies
Most Recent Scoops
Hiring Plans
AIVITA Biomedical has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: Ideal.
Hiring Plans
Executive Move
Person-Based
Executive Moves, Personnel Moves, Board of Directors, Business Development, Corporate Strategy
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Executive Move
Board of Directors
Funding
AIVITA Biomedical News & Media
LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum
ASHEVILLE, N.C., July 10, 2025 /PRNewswire/ -- LevEllis, Inc. a pioneering skincare company founded by renowned surgeon and molecular biologist, Laura Ellis, MD, and guided by a distinguished scientific advisory board, is excited to announce the official launch of PROVOQUE™, a...AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
IRVINE, Calif.--(BUSINESS WIRE)--AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, is pleased to announce the execution of a licensing agreement with LevEllis, a global skincare retailer, for the worldwide exclusive marketing and distribution rights to AIVITA’s proprietary skincare formulations. Formerly sold as Root of Skin™, AIVITA’s skincare products generated strong market testing metrics amongst licensed clinical dermatologists and set records foAIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
IRVINE, Calif., April 11, 2024 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans Keirstead, Ph.D. and chief medical officer Robert Dillman, M.D. will speak and participate in a...
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AIVITA Biomedical
Sign Up For FreeTo access detailed company insights
AIVITA Biomedical is a biotechnology company focused on developing personalized vaccines for the prevention of infectious diseases and the treatment of cancer. They utilize a unique pan-antigenic approach to target all neoantigens, allowing their cancer treatments to adapt to mutations over time. Their autologous cell therapy platform has produced... Read More
